Researchers continue to excited about this new drug, a novel dual treatment showing promising outcomes in early trials for weight loss . It acts by targeting both systems: GLP-1 and GIP, that , when https://jaysonsczt420156.educationalimpactblog.com/62307359/the-new-hope-for-size-reduction